Liver mass MRI: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
m (Bot: Removing from Primary care) |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Liver mass}} | {{Liver mass}} | ||
{{CMG}}{{AE}}{{MV}} | {{CMG}}; {{AE}}{{MV}} | ||
==Overview== | ==Overview== | ||
On MRI, characteristic features for the diagnosis of liver mass, include: higher soft tissue contrast, lack of radiation exposure, lesion characterization by evaluation of signal intensities, improving detection of hypervascular lesions, and characterization of the dynamics of contrast uptake.<ref name="pmid22541698">{{cite journal |vauthors=Bonder A, Afdhal N |title=Evaluation of liver lesions |journal=Clin Liver Dis |volume=16 |issue=2 |pages=271–83 |year=2012 |pmid=22541698 |doi=10.1016/j.cld.2012.03.001 |url=}}</ref> | On MRI, characteristic features for the diagnosis of liver mass, include: higher soft tissue contrast, lack of radiation exposure, lesion characterization by evaluation of signal intensities, improving detection of hypervascular lesions, and characterization of the dynamics of contrast uptake.<ref name="pmid22541698">{{cite journal |vauthors=Bonder A, Afdhal N |title=Evaluation of liver lesions |journal=Clin Liver Dis |volume=16 |issue=2 |pages=271–83 |year=2012 |pmid=22541698 |doi=10.1016/j.cld.2012.03.001 |url=}}</ref> | ||
==MRI== | ==MRI== | ||
On MRI, characteristic features for the diagnosis of liver mass, include: | On MRI, characteristic features for the diagnosis of liver mass, include: | ||
*Higher soft tissue contrast | |||
*Lack of radiation exposure | |||
*Lesion characterization by evaluation of signal intensities | |||
*Improving detection of hypervascular lesions | |||
*Characterization of the dynamics of contrast uptake | |||
{| | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ultrasound | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |CT scan | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |MRI | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Hepatocellular adenoma | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Heterogeneous | |||
* Hyperechoic if steatotic | |||
* Anechoic center if hemorrhage | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Well demarcated with peripheral enhancement | |||
* Homogenous more often than heterogeneous | |||
* Hypodense if steatotic | |||
* Hyperdense if hemorrhagic | |||
| align="left" style="background:#F5F5F5;" + | | |||
* HNF1 α: signal lost on chemical shift; moderate arterial enhancement without persistent enhancement during the delayed phase | |||
* IHCA: markedly hyperintense on T2 with stronger signal peripherally; persistent enhancement in the delayed phase | |||
* β-Catenin: inflammatory subtype has the same appearance as IHCA | |||
** Noninflammatory is heterogeneous with no signal dropout on chemical shift | |||
** Isointense of T1 and T2 with strong arterial enhancement and delayed washout | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Hemangioma | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Hyperechoic with well-defined rim and with few intranodular vessels | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Discontinuous peripheral nodular enhancement | |||
* Isoattenuating to the aorta with progressive centripetal fill-in | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: Hypointense; discontinuous peripheral enhancement with centripetal fill-in | |||
* T2: Hyperintense relative to spleen | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |FNH | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Generally isoechoic | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Central scar | |||
* Arterial phase shows homogenous hyperdense lesion | |||
* Returns to precontrast density during the portal phase that is hypo or isodense | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: Isointense or slightly hypointense. Gadolinium produces early enhancement with central scar enhancement during the delayed phase | |||
* T2: Slightly hyperintense or isointense | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |NRH | |||
| align="left" style="background:#F5F5F5;" + | | |||
*Isoechoic/hyperechoic | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Nonenhancing nodules, sometimes hypodense, with variable sizes (most sub-centimeter) | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: hyperintense | |||
* T2: varied intensity (hypo/iso/hyperintense) | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Simple hepatic cysts (SHCs) | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Anechoic | |||
* Homogeneous | |||
* Fluid filled | |||
* Smooth margins | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Well-demarcated | |||
* Water-attenuated | |||
* Smooth lesion without an internal structure | |||
* No enhancement with contrast | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: hypointense signal intensity | |||
* T2: hyperintense signal intensity | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Biliary cystadenomas (BCs) | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Irregular walls | |||
* Internal septations forming loculi | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Heterogeneous | |||
* Internal septations | |||
* Irregular papillary growths | |||
* Thickened cyst walls | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: Hypointense signal intensity | |||
* T2: Hyperintense signal intensity | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Hydatid cysts (HCs) | |||
| align="left" style="background:#F5F5F5;" + | | |||
* May appear similar to SHC. | |||
** Progress to develop | |||
** Thick calcified walls | |||
** Hyperechoic/hypoechoic contents. | |||
* Daughter cysts in the periphery | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Hypodense lesion with hypervascular pericyst wall | |||
* Distinct endocyst wall | |||
* Calcified walls and septa | |||
* Daughter cysts within the periphery of the mother cyst | |||
| align="left" style="background:#F5F5F5;" + | | |||
* T1: Hypointense signal intensity of cyst contents | |||
* T2: Hyperintense signal intensity of cyst contents | |||
* Hypointense rim on T2 | |||
* Daughter cysts within the periphery of the mother cyst | |||
* Collapse parasitic membranes as floating linear structures within cyst | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Surgery]] | [[Category:Surgery]] |
Latest revision as of 22:32, 29 July 2020
Liver Mass Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liver mass MRI On the Web |
American Roentgen Ray Society Images of Liver mass MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
On MRI, characteristic features for the diagnosis of liver mass, include: higher soft tissue contrast, lack of radiation exposure, lesion characterization by evaluation of signal intensities, improving detection of hypervascular lesions, and characterization of the dynamics of contrast uptake.[1]
MRI
On MRI, characteristic features for the diagnosis of liver mass, include:
- Higher soft tissue contrast
- Lack of radiation exposure
- Lesion characterization by evaluation of signal intensities
- Improving detection of hypervascular lesions
- Characterization of the dynamics of contrast uptake
Disease | Ultrasound | CT scan | MRI |
---|---|---|---|
Hepatocellular adenoma |
|
|
|
Hemangioma |
|
|
|
FNH |
|
|
|
NRH |
|
|
|
Simple hepatic cysts (SHCs) |
|
|
|
Biliary cystadenomas (BCs) |
|
|
|
Hydatid cysts (HCs) |
|
|
|
References
- ↑ Bonder A, Afdhal N (2012). "Evaluation of liver lesions". Clin Liver Dis. 16 (2): 271–83. doi:10.1016/j.cld.2012.03.001. PMID 22541698.